University Health Network, Toronto: Neoplasm Metastasis trials
The registry lists 29 Neoplasm Metastasis studies with University Health Network, Toronto as lead sponsor. 5 are open to participants now and 0 have results posted.
Phase 1 6Phase 2 12Phase 3 1No phase 14(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic CancerNot yet recruitingNCT07665684Phase 1/2
- In Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to LungRecruitingNCT05611034Phase 1
- Patient Reported Outcomes/Metrics Program TrialRecruitingNCT04983199
- Immune Resistance Interrogation StudyRecruitingNCT04243720
- Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching HostRecruitingNCT02732860
- Study of NABPLAGEM vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Pancreatic CancerActive, not recruitingNCT06783140Phase 2/3
- Phase 1 Study of RP-6306 With Carboplatin and Paclitaxel in TP53 Ovarian and Uterine CancerActive, not recruitingNCT06107868Phase 1
- Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic TherapyActive, not recruitingNCT03712566
- Cognitive Support Program for Patients With Brain MetastasesCompletedNCT03537911Not applicable
- A Study of Avelumab in Penile Cancer Who Are Unfit for or Have Progressed After Platinum-Based ChemotherapyActive, not recruitingNCT03391479Phase 2
- Comprehensive Genomic Profiling of Colorectal Cancer Patients With Isolated Liver Metastases to Understand Response & Resistance to Cancer TherapyActive, not recruitingNCT03364621
- A Study of Hypoxia Imaging in Advanced Pancreatic Cancer Patients Being Treated With Gemcitabine and TH-302 or TH-302 PlaceboWithdrawnNCT02496832Not applicable
- Toronto BNB Pilot StudyCompletedNCT02082587
- A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of GenesCompletedNCT02069730Not applicable
- A Study of Pancreatic Cancer in Xenografts From Liver MetastasesCompletedNCT01774643
- Study of AUY922 in Metastatic Pancreatic Cancer Who Are Resistant to First Line ChemotherapyTerminatedNCT01484860Phase 2
- Surgery Versus Radiosurgery for the Treatment of Single Brain MetastasesWithdrawnNCT01295970Not applicable
- Stereotactic Body Radiotherapy (SBRT) for Spinal/Para-Spinal Metastases (Spine SBRT)CompletedNCT01290562Phase 2
- A Study of Perioperative Chemotherapy Plus Panitumumab in Patients With Colorectal Cancer Liver MetastasesCompletedNCT01260415Phase 2
- Comparison of Primovist-enhanced MRI, Diffusion Weighted MRI and Multidetector CT of Colorectal Liver MetastasesCompletedNCT01255007Not applicable
- Risk Factors for Skeletal Related Events in Breast Cancer Patients Receiving Bisphosphonates for Bone MetastasesCompletedNCT01144481
- Palliative Radiotherapy (RT) for Liver Metastases (Mets) and Hepatocellular Carcinoma (HCC)(COLD 4)CompletedNCT00923897Phase 2
- Stereotactic Body Radiation Therapy (SBRT) in Liver Metastasis (COLD 3)CompletedNCT00914615Phase 2
- Sorafenib-RT Treatment for Liver Metastasis (SLIM)CompletedNCT00892424Phase 1/2
- Perfexion Brain MetastasisTerminatedNCT00805103Phase 1
- Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Kidney RemovalCompletedNCT00480389Phase 2
- Comparison of Triphasic CT, PET and MR Tumour With Pathological Findings in Colorectal Cancer Liver MetastasesCompletedNCT00242086Not applicable
- Dexamethasone for Palliation - Brain MetastasesCompletedNCT00188864Phase 2
- Stereotactic Radiotherapy (SRT) Liver (COLD 1)CompletedNCT00152906Phase 1/2